fbpx
Medical Innovation Exchange

TeneoTwo, put in play by Amgen, lands $100M AstraZeneca buyout on back of blood cancer bispecific

https://www.fiercebiotech.com/biotech/teneotwo-put-play-amgen-lands-100m-astrazeneca-buyout-back-blood-cancer-bispecific

Leave a Comment

Your email address will not be published.

Leave the field below empty!

This site uses Akismet to reduce spam. Learn how your comment data is processed.